Immune therapy tested for Kids' Sudden-Onset OCD

NCT ID NCT04508530

Summary

This Phase 3 trial tested whether an immune therapy called Panzyga (IVIG) could reduce severe obsessive-compulsive and behavioral symptoms in children with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS). The study involved 71 children and teenagers, comparing Panzyga infusions to a placebo over 9 weeks to see which better improved symptoms. The goal was to see if this treatment could help control this difficult-to-treat condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Octapharma Research Site

    Tucson, Arizona, 85712, United States

  • Octapharma Research Site

    Little Rock, Arkansas, 72202, United States

  • Octapharma Research Site

    Los Angeles, California, 90024, United States

  • Octapharma Research Site

    Palo Alto, California, 94305, United States

  • Octapharma Research Site

    Centennial, Colorado, 80112, United States

  • Octapharma Research Site

    Boston, Massachusetts, 02114, United States

  • Octapharma Research Site

    Lebanon, New Hampshire, 03756, United States

  • Octapharma Research Site

    Genova, 16147, Italy

  • Octapharma Research Site

    Roma, 00161, Italy

  • Octapharma Research Site

    Roma, 00186, Italy

  • Octapharma Research Site

    Gothenburg, 41685, Sweden

  • Octapharma Research Site

    Stockholm, 17164, Sweden

Conditions

Explore the condition pages connected to this study.